Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study
- PMID: 15676035
- PMCID: PMC1884748
- DOI: 10.1111/j.1365-2125.2004.02232.x
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study
Abstract
Objectives: To measure the association between the use of drugs with anticholinergic properties and cognitive performance in an elderly population, the PAQUID cohort.
Methods: The sample studied was composed of 1780 subjects aged 70 and older, living at home in South western France. Data on socio-demographic characteristics, medical history and drug use were collected using a standardized questionnaire. Cognitive performance was assessed using the following neuropsychological tests: the Mini-Mental State Examination (MMSE) which evaluates global cognitive functioning, the Benton Visual Retention Test (BVRT) which assesses immediate visual memory, and the Isaacs' Set Test (IST) which assesses verbal fluency. For each test, scores were dichotomized between low performance and normal to high performance using the score at the 10th percentile of the study sample as the cut-off point, according to age, gender and educational level. The association between the use of drugs with anticholinergic properties and cognitive performance was examined using logistic regression models, adjusting for several potential confounding factors.
Results: About 13.7% of the subjects used at least one drug with anticholinergic properties. In multivariate analyses, the use of these drugs was significantly associated with low performance in the BVRT [odds ratio (OR) = 1.6; 95% confidence interval (CI) 1.1, 2.3] and in the IST (OR = 1.9; 95% CI 1.3, 2.8). The association found with low performance in the MMSE (OR = 1.4; 95% CI 1.0, 2.1) was barely statistically significant.
Conclusion: These findings suggest that the use of drugs with anticholinergic properties is associated with low cognitive performance among community-dwelling elderly people.
Similar articles
-
Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.J Am Geriatr Soc. 2009 Mar;57(3):427-31. doi: 10.1111/j.1532-5415.2008.02129.x. J Am Geriatr Soc. 2009. PMID: 19278396
-
Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study.J Clin Psychopharmacol. 2008 Dec;28(6):654-9. doi: 10.1097/JCP.0b013e31818ce849. J Clin Psychopharmacol. 2008. PMID: 19011434
-
Anticholinergic drugs and physical function among frail elderly population.Clin Pharmacol Ther. 2007 Feb;81(2):235-41. doi: 10.1038/sj.clpt.6100035. Epub 2006 Dec 27. Clin Pharmacol Ther. 2007. PMID: 17192773 Clinical Trial.
-
Anticholinergic and sedative medicines - prescribing considerations for people with dementia.Aust Fam Physician. 2012 Jan-Feb;41(1-2):45-9. Aust Fam Physician. 2012. PMID: 22276284 Review.
-
[Drug-induced cognitive impairment].Brain Nerve. 2012 Dec;64(12):1405-10. Brain Nerve. 2012. PMID: 23209067 Review. Japanese.
Cited by
-
Regulators of cholinergic signaling in disorders of the central nervous system.J Neurochem. 2021 Sep;158(6):1425-1438. doi: 10.1111/jnc.15332. Epub 2021 Mar 19. J Neurochem. 2021. PMID: 33638173 Free PMC article. Review.
-
Association of Anticholinergic Use with Incidence of Alzheimer's Disease: Population-based Cohort Study.Sci Rep. 2019 May 1;9(1):6802. doi: 10.1038/s41598-019-43066-0. Sci Rep. 2019. PMID: 31043628 Free PMC article.
-
Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.Drugs Aging. 2020 Apr;37(4):301-310. doi: 10.1007/s40266-019-00743-z. Drugs Aging. 2020. PMID: 31930459
-
Impact of Anticholinergic Burden on Cognitive Performance: A Cohort Study of Community-Dwelling Older Adults.J Am Med Dir Assoc. 2020 Sep;21(9):1357-1358.e3. doi: 10.1016/j.jamda.2020.03.027. Epub 2020 May 10. J Am Med Dir Assoc. 2020. PMID: 32402780 Free PMC article. No abstract available.
-
Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?Res Rep Urol. 2017 Oct 31;9:209-218. doi: 10.2147/RRU.S146746. eCollection 2017. Res Rep Urol. 2017. PMID: 29184855 Free PMC article. Review.
References
-
- Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry. 1996;57(Suppl 5):38–44. - PubMed
-
- Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21:101–22. - PubMed
-
- Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15:15–28. - PubMed
-
- Lagnaoui R, Begaud B, Moore N, et al. Benzodiazepine use and risk of dementia: a nested case–control study. J Clin Epidemiol. 2002;55:314–8. - PubMed
-
- Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th edn. Edinburgh: Churchill Livingstone; 2003.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical